Sumayang, Tomas L.
HRN: 04-12-21 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/12/2026
CEFTRIAXONE 1G (VIAL)
07/12/2026
07/18/2026
IV
2g
OD
Avulsed Wound
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes